WebRSK is a serine/threonine kinase containing two distinct catalytic domains. Found at the terminus of the Ras/extracellular signal-regulated kinase (ERK)-mitogen-activated protein kinase (MAPK) kinase cascade, mitogen-stimulated ribosomal S6 kinase (RSK) activity requires multiple inputs. WebOct 28, 2013 · These results demonstrate that RSK activation of eIF4B is causally linked to elevated Lamγ2 and MYC protein levels during neoplastic progression to invasive SCC. These findings have potential clinical significance for identifying premalignant lesions and for developing targeted drugs to treat SCC. Publication types Research Support, Non-U.S. …
Ribosomal s6 kinase - Wikipedia
WebSep 9, 2015 · Sustained ERK-RSK activation and substrates during KSHV lytic replication. Extracellular mitogen-like stimuli or glycoproteins of KSHV virion trigger transient ERK-RSK activation to induce expression of the IE genes RTA, K8 and ORF45 during the IE stage of primary infection or reactivation from latency. Consequently, ORF45 and other viral ... In molecular biology, ribosomal s6 kinase (rsk) is a family of protein kinases involved in signal transduction. There are two subfamilies of rsk, p90 , also known as MAPK-activated protein kinase-1 (MAPKAP-K1), and p70 , also known as S6-H1 Kinase or simply S6 Kinase. There are three variants of p90 in humans, rsk 1-3. Rsks are serine/threonine kinases and are activated by the MAPK/ERK p… refoundstore.ca
RSK activation of translation factor eIF4B drives abnormal
WebAug 1, 2006 · RSK [for 90 kDa ribosomal S6 kinase (p90 rsk); also known as MAPKAP-K1] and MSK (for mitogen- and stress-activated protein kinase) constitute a family of protein … WebJul 1, 2024 · RSK activation via ERK modulates human colon cancer cells response to PTHrP in: Journal of Molecular Endocrinology Volume 59 Issue 1 (2024) Parathyroid hormone-related peptide (PTHrP) is associated with … WebJun 14, 2024 · We revealed that TIFA mediates RSK and PRAS40 activation to facilitate protein synthesis, which relied on TIFA oligomerization (T9) and TRAF6 binding (E178) in vitro and in vivo. We also showed that RSK inhibitor and PRAS40 shRNAs, which prevent RSK and PRAS40 activation, could significantly suppress TIFA‐mediated CRC cell proliferation. refound logistics corp